Fahrtauglichkeit unter Schmerzmedikamenten.

Paragraph 2 of the Driving License Ordinance (FeV) defines the relevant share of responsibility for every vehicle driver: Those who cannot move safely in traffic and pose a risk to themselves or others must refrain from driving a motor vehicle. The taking of medication should not be assessed differently from symptoms caused by a severe flu-like infection or gastrointestinal disorder. The assessment of drivers who have been treated with painkillers on a long-term basis with regard to their ability to safely participate in road traffic is complex and, including fundamental considerations, generally also requires a case-by-case approach and, if necessary, an assessment. The typical undesirable effects of most pain medication, especially WHO II and III, can potentially and usually only temporarily put this fitness to drive into question. On the other hand, taking painkillers can make driving possible in the first place. The ability to drive can be impaired in particular when dosing, changing substances, changing doses, supplementing co-medication and also discontinuing substances. A period of 2 weeks for not driving a motor vehicle can be considered useful here. The requirement for safety is to be set even higher for driving license group 2, professional drivers, bus drivers, passenger transport. In this context, road users are required to have a high level of character aptitude. There are trend-setting publications penned by the assessment criteria working group of the German Society for Traffic Psychology (DGVP). [ABSTRACT FROM AUTHOR]